Last update 11 Oct 2026
Shanghai Weike Biological Technology Co., Ltd.

Shanghai Weike Biological Technology Co., Ltd.

Private Company|2002|Shanghai Shi, China|
www.weike21.com

Overview

Tags

Neoplasms
Respiratory Diseases
Tumor necrosis factors

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms1
Top 5 Drug TypeCount
Tumor necrosis factors1
Top 5 TargetCount
TNFR(Tumor necrosis factor receptor)1

Related

1
Drugs associated with Shanghai Weike Biological Technology Co., Ltd.
Recombinant mutant human tumor necrosis factor
Target
TNFR
Mechanism
TNFR modulators
Active Org.
Shanghai Wellcares Biopharmaceutical Co.,Ltd.Shanghai Wellcares Biopharmaceutical Co.,Ltd. [+1]
Originator Org.
Shanghai Wellcares Biopharmaceutical Co.,Ltd.Shanghai Wellcares Biopharmaceutical Co.,Ltd.
Active Indication
Non-Small Cell Lung Cancer [+2]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
China
First Approval Date12 Jul 2004
100 Clinical Results associated with Shanghai Weike Biological Technology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Shanghai Weike Biological Technology Co., Ltd.
Login to view more data
100 Deals associated with Shanghai Weike Biological Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shanghai Weike Biological Technology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Oct 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Recombinant mutant human tumor necrosis factor
 ( TNFR )		Non-Small Cell Lung Cancer
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free